Tectonic Therapeutic (TECX) Cash from Financing Activities (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Cash from Financing Activities data on file, last reported at $847000.0 in Q1 2026.

• On a quarterly basis, Cash from Financing Activities fell 99.52% year-over-year to $847000.0 in Q1 2026; TTM through Mar 2026 was -$3.9 million, a 101.12% decrease from a year earlier, with the FY2025 full-year figure at $173.4 million, up 0.96% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $847000.0, up from -$141000.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for TECX reached as high as $179.7 million in Q2 2024 and fell as low as -$6.3 million in Q3 2024.
• Historically, Cash from Financing Activities has averaged $22.3 million across 5 years, with a median of $1000.0 in 2022.
• On a YoY basis, Cash from Financing Activities climbed as much as 57747.46% in 2023 and fell as far as 32500.0% in 2023.
• Year by year, Cash from Financing Activities stood at $59000.0 in 2022, then surged by 57747.46% to $34.1 million in 2023, then tumbled by 103.13% to -$1.1 million in 2024, then soared by 86.81% to -$141000.0 in 2025, then soared by 700.71% to $847000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $847000.0 in Q1 2026, -$141000.0 in Q4 2025, and -$457000.0 in Q3 2025.